LON:C4XD C4X Discovery (C4XD) Share Price, News & Analysis → It’s now possible to know the win rate of every trade… BEFORE you take it! (From WealthPress) (Ad) Free C4XD Stock Alerts GBX 12 +2.57 (+27.25%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range 8.30▼ 1250-Day Range 7.35▼ 14.8552-Week Range 7▼ 22Volume3.77 million shsAverage Volume1.22 million shsMarket Capitalization£30.27 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlines Get C4X Discovery alerts: Email Address Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. About C4X Discovery Stock (LON:C4XD)C4X Discovery Holdings plc operates as drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules. Its product pipeline includes Orexin-1, a receptor antagonist for the treatment of addictive disorders; NRF-2 activator to treat various inflammatory diseases; IL-17A inhibitor for inflammation diseases; a4ß7 integrin inhibitors for the treatment of inflammatory bowel disease; and MALT-1 inhibitors to treat hematological cancer. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. C4X Discovery Holdings plc was incorporated in 2007 and is based in Manchester, the United Kingdom.Read More C4XD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart C4XD Stock News HeadlinesApril 17, 2024 | americanbankingnews.comC4X Discovery (LON:C4XD) Stock Price Passes Below 50-Day Moving Average of $11.58March 27, 2024 | marketwatch.comC4X Discovery to Delist From AIM Due to Downturn in Financial MarketsApril 25, 2024 | Colonial Metals (Ad)The Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.March 27, 2024 | msn.comAnother listed company plans to quit London’s AIM market – this is whyFebruary 26, 2024 | msn.comSMALL CAP IDEA: AIM healthcare stock C4X struggles for market reward despite business progressJanuary 26, 2024 | finance.yahoo.comHere's Why We're Watching C4X Discovery Holdings' (LON:C4XD) Cash Burn SituationJanuary 23, 2024 | morningstar.comC4X Discovery Holdings PLC C4XDJanuary 3, 2024 | msn.comUK grocery price inflation slows to 6.7% as retailers enjoy busiest Christmas since 2019, data shows – business liveApril 25, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…January 3, 2024 | marketwatch.comC4X Discovery Shares Rise on AstraZeneca Milestone PaymentJanuary 3, 2024 | thetimes.co.ukAstraZeneca payout pushes C4X share price up 50%December 20, 2023 | lse.co.ukPosting of 2023 Annual Report and Notice of AGMDecember 16, 2023 | finance.yahoo.comC4X Discovery Holdings plc (LON:C4XD) Is About To Turn The CornerOctober 30, 2023 | news.yahoo.comCustoms and Border Protection makes bizarre discovery at O'HareAugust 7, 2023 | finance.yahoo.comC4X Discovery focused and funded after £15.95mln strategic divestmentAugust 1, 2023 | marketwatch.comC4X Discovery Sells Substance Use Treatment Rights to Indivior for GBP16 MlnJuly 19, 2023 | finance.yahoo.comThe past five years for C4X Discovery Holdings (LON:C4XD) investors has not been profitableJune 20, 2023 | marketwatch.comC4X Discovery Chair Steps Down; CEO Named Interim ChairJune 8, 2023 | finance.yahoo.comIs C4X Discovery Holdings (LON:C4XD) In A Good Position To Invest In Growth?June 1, 2023 | lse.co.ukC4X says MALT-1 study shows no UGT1A1 liability seen in competitorsApril 28, 2023 | finance.yahoo.comC4X Discovery Holdings First Half 2023 Earnings: UK£0.015 loss per share (vs UK£0.02 loss in 1H 2022)April 26, 2023 | finance.yahoo.comC4X Discovery Holdings PLC Announces Half Year ResultsApril 26, 2023 | finance.yahoo.comC4X Discovery Holdings plc: Half-year results for the six months ended 31 January 2023April 13, 2023 | barrons.comWarner Bros. Discovery Stock Will Climb on DC Superhero Films: AnalystFebruary 22, 2023 | finance.yahoo.comC4XD and Garvan Institute of Medical Research report successful patient stratification approach using C4XD's new precision medicine platform PatientSeekFebruary 19, 2023 | uk.finance.yahoo.comC4X Discovery Holdings plc (C4XD.L)January 15, 2023 | reuters.comC4XD.L - | Stock Price & Latest News | ReutersSee More Headlines Receive C4XD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for C4X Discovery and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/29/2020Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:C4XD CUSIPN/A CIKN/A Webwww.c4xdiscovery.com Phone+44-161-2355085FaxN/AEmployees49Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-11,110,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-121.19% Return on Assets-71.76% Debt Debt-to-Equity Ratio6.49 Current Ratio3.28 Quick Ratio9.82 Sales & Book Value Annual Sales£1.71 million Price / Sales13.87 Cash FlowGBX 2.35 per share Price / Cash Flow4.00 Book ValueGBX 3 per share Price / Book3.13Miscellaneous Outstanding Shares252,230,000Free FloatN/AMarket Cap£23.71 million OptionableNot Optionable Beta0.27 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesDr. Clive James Dix B.Sc. (Age 70)Ph.D., Interim Executive Chairman & CEO Comp: $211kMr. Bradley Richard Hoy (Age 62)CFO, Secretary & Executive Director Comp: $242kMs. Bhavna Hunjan (Age 39)Chief Business Officer & Executive Director Comp: $218kMs. Emma Blaney Ph.D.Chief Operating OfficerDr. Nick Ray Ph.D.Chief Scientific OfficerDr. Clare Murray Ph.D.Senior Vice President of Drug DiscoveryMore ExecutivesKey CompetitorsSareumLON:SARHemogenyx PharmaceuticalsLON:HEMOOKYO PharmaLON:OKYODestiny PharmaLON:DESTAorTech InternationalLON:AORView All CompetitorsInsidersClive DixBought 485,320 shares on 4/8/2024Total: £4.85 M ($10.00/share) C4XD Stock Analysis - Frequently Asked Questions Should I buy or sell C4X Discovery stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for C4X Discovery in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" C4XD shares. View C4XD analyst ratings or view top-rated stocks. How have C4XD shares performed in 2024? C4X Discovery's stock was trading at GBX 9 on January 1st, 2024. Since then, C4XD stock has increased by 33.3% and is now trading at GBX 12. View the best growth stocks for 2024 here. How were C4X Discovery's earnings last quarter? C4X Discovery Holdings plc (LON:C4XD) announced its earnings results on Wednesday, April, 29th. The company reported ($5.02) EPS for the quarter, beating analysts' consensus estimates of ($5.50) by $0.48. What other stocks do shareholders of C4X Discovery own? Based on aggregate information from My MarketBeat watchlists, some companies that other C4X Discovery investors own include Rio Tinto Group (RIO), Ryder System (R), Pearson (PSON), Moss Bros Group (MOSB), Inland Homes (INL), Fundsmith Emerging Equities Trust (FEET), easyJet (EZJ), Card Factory (CARD) and The Berkeley Group (BKG). How do I buy shares of C4X Discovery? Shares of C4XD stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:C4XD) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding C4X Discovery Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
